Du, Y., Zhang, X., Ma, N., Yang, W., Yang, B., Su, F., Zong, L., Hu, W., Zhao, J. (2025). An exploratory phase II trial of low-dose decitabine and sintilimab combined with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.390